324 related articles for article (PubMed ID: 35897925)
1. Epithelial-Mesenchymal Transition-Mediated Tumor Therapeutic Resistance.
Xu Z; Zhang Y; Dai H; Han B
Molecules; 2022 Jul; 27(15):. PubMed ID: 35897925
[TBL] [Abstract][Full Text] [Related]
2. Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition.
Jin W
Cells; 2020 Jan; 9(1):. PubMed ID: 31952344
[TBL] [Abstract][Full Text] [Related]
3. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.
Du B; Shim JS
Molecules; 2016 Jul; 21(7):. PubMed ID: 27455225
[TBL] [Abstract][Full Text] [Related]
4. The network of epithelial-mesenchymal transition: potential new targets for tumor resistance.
Nantajit D; Lin D; Li JJ
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1697-713. PubMed ID: 25270087
[TBL] [Abstract][Full Text] [Related]
5. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D
Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823
[TBL] [Abstract][Full Text] [Related]
6. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
7. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
Liu X; Fan D
Curr Pharm Des; 2015; 21(10):1279-91. PubMed ID: 25506898
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.
Ginnebaugh KR; Ahmad A; Sarkar FH
Expert Opin Ther Targets; 2014 Jul; 18(7):731-45. PubMed ID: 24758643
[TBL] [Abstract][Full Text] [Related]
9. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-to-Mesenchymal Transition: Liaison between Cancer Metastasis and Drug Resistance.
Du F; Liu H; Lu Y; Zhao X; Fan D
Crit Rev Oncog; 2017; 22(3-4):275-282. PubMed ID: 29604904
[TBL] [Abstract][Full Text] [Related]
11. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.
Garg M
Expert Opin Ther Targets; 2015 Feb; 19(2):285-97. PubMed ID: 25563894
[TBL] [Abstract][Full Text] [Related]
12. The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression.
Fedele M; Sgarra R; Battista S; Cerchia L; Manfioletti G
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054987
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of F-box proteins in the regulation of epithelial-mesenchymal transition and stem cells in human cancers.
Song Y; Lin M; Liu Y; Wang ZW; Zhu X
Stem Cell Res Ther; 2019 Apr; 10(1):124. PubMed ID: 30999935
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y
BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823
[TBL] [Abstract][Full Text] [Related]
15. Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics.
Dang H; Ding W; Emerson D; Rountree CB
BMC Cancer; 2011 Sep; 11():396. PubMed ID: 21929801
[TBL] [Abstract][Full Text] [Related]
16. Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer.
Li P; Yang R; Gao WQ
Mol Cancer; 2014 Mar; 13():55. PubMed ID: 24618337
[TBL] [Abstract][Full Text] [Related]
17. A pre-existing population of ZEB2
Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A
J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4
Liu L; Zhu H; Liao Y; Wu W; Liu L; Liu L; Wu Y; Sun F; Lin HW
Biomed Pharmacother; 2020 Jul; 127():110225. PubMed ID: 32428834
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-to-mesenchymal transition in tumor progression.
Prieto-García E; Díaz-García CV; García-Ruiz I; Agulló-Ortuño MT
Med Oncol; 2017 Jul; 34(7):122. PubMed ID: 28560682
[TBL] [Abstract][Full Text] [Related]
20. The epithelial to mesenchymal transition in pancreatic cancer: A systematic review.
Beuran M; Negoi I; Paun S; Ion AD; Bleotu C; Negoi RI; Hostiuc S
Pancreatology; 2015; 15(3):217-25. PubMed ID: 25794655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]